Effects of a depression-focused internet intervention in patients with acute pain: A randomized controlled trial

Effects of a depression-focused internet intervention in patients with acute pain: A randomized controlled trial - SP-Novego

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

DRKS

Registry ID

DRKS00015222

Enrollment

Registered

2018-08-03

Start date

2018-08-06

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F32 R52

Interventions

Group 1: Interventional = Internet-intervention " novego – Depressionen bewältigen" focusing on treating depressive symptoms Group 2: Wait-list control group = does not receive any additional treatme

gains access to “novego – Depressionen bewältigen“ and a mindfulness manual after completion of the post survey

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: •age: 18 to 75 years old •consent to participate in study (informed consent) •internet access •sufficient understanding of the German language •willingness to participate in two anonymous online surveys, each of which lasts approx. 25-30 minutes •willingness to participate in an 12-week training program •willingness to use the program on one's own responsibility •willingness to provide an e-mail address •presence of current or reported depressive symptoms •acute pain (with a focus on back pain, 1/3 participants with back pain are planned to be recruited)

Exclusion criteria

Exclusion criteria: •lifetime schizophrenic or bipolar symptoms •acute suicidal tendencies

Design outcomes

Primary

Measure	Time frame
Beck Depression Inventar-II (BDI-II): A self-rating questionnaire to measure depressive symptoms over the past two weeks	—

Secondary

Measure	Time frame
Patient Health Questionnaire-9 (PHQ-9): A self-rating questionnaire to measure depressive symptoms over the past week (at baseline- and post-assessment). Quality of Life (WHO-QOL-BREF): Self-report questionnaire that measures the quality of life across the domains of physical and psychological health as well as social interactions and the environment during the last two weeks (at baseline- and post-assessment). German Pain Questionnaire (DSF): Self-report questionnaire for the multidimensional pain assessment (e.g., pain locality, temporal pain characteristics, pain relieving and pain intensifying factors, treatment of pain etc.; at baseline- and post-assessment). Visual Analog Scale (VAS): One item that measures pain intensity on a scale ranging from 0 (no pain) to 10 (unbearable pain) during the last seven days (at baseline- and post-assessment). University of Rhode Island Change Assessment Scale (URICA): Self-report questionnaire that assesses the stage of change (at baseline assessment). Credibility/Expectancy Questionnaire (CEQ): One item that measures treatment expectations (at baseline assessment). Questionnaire on patient satisfaction in modified version (ZUF-8): Self-report questionnaire that measures the global patient satisfaction at the end of treatment (post-assessment).	—

Measure

Time frame

Patient Health Questionnaire-9 (PHQ-9): A self-rating questionnaire to measure depressive symptoms over the past week (at baseline- and post-assessment). Quality of Life (WHO-QOL-BREF): Self-report questionnaire that measures the quality of life across the domains of physical and psychological health as well as social interactions and the environment during the last two weeks (at baseline- and post-assessment). German Pain Questionnaire (DSF): Self-report questionnaire for the multidimensional pain assessment (e.g., pain locality, temporal pain characteristics, pain relieving and pain intensifying factors, treatment of pain etc.; at baseline- and post-assessment). Visual Analog Scale (VAS): One item that measures pain intensity on a scale ranging from 0 (no pain) to 10 (unbearable pain) during the last seven days (at baseline- and post-assessment). University of Rhode Island Change Assessment Scale (URICA): Self-report questionnaire that assesses the stage of change (at baseline assessment). Credibility/Expectancy Questionnaire (CEQ): One item that measures treatment expectations (at baseline assessment). Questionnaire on patient satisfaction in modified version (ZUF-8): Self-report questionnaire that measures the global patient satisfaction at the end of treatment (post-assessment).

—

Countries

Germany

Contacts

Public ContactSteffen Moritz

Universitätsklinikum Hamburg Eppendorf, Klinik für Psychiatrie und Psychotherapie

moritz@uke.de+4940741056565

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026